Back to Search

ANDREA DELEO, D.O., M.S.E.

D.O., M.S.E.

Neurology Physician

NPI: 1265436042IndividualAccepts Medicare

Specialties, Licenses & Credentials

Neurology PhysicianPrimary

Psychiatry & Neurology — Neurology

Code: 2084N0400X

64428(CT)02002174A(IN)

CMS Specialties

PrimaryNEUROLOGY

Education

PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE

Class of 1992

Research & Publications (20)

Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
PMID 18767952·Expert Rev Vaccines·2008
6-review
Lower extremity joint coupling during running: a current update.
PMID 15531047·Clin Biomech (Bristol)·2004
6-review
Resident's case problem: diagnosis and treatment of posterolateral instability in a patient with lateral collateral ligament sprain.
PMID 12723675·J Orthop Sports Phys Ther·2003
5-case
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
PMID 19562340·Cancer Immunol Immunother·2010
7-preclinical
Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
PMID 19296526·Head Neck·2009
4-observational
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
PMID 19184003·Cancer Immunol Immunother·2009
8-other
Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
PMID 17974998·Cancer Res·2007
8-other
Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides.
PMID 17631051·Clin Immunol·2007
8-other
Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
PMID 17294448·Int J Cancer·2007
8-other
The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.
PMID 17082593·J Immunol·2006
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
801 MACARTHUR BLVD, STE 404
MUNSTER, IN 46321

Locations (2)

Practice Location

801 MACARTHUR BLVD, MUNSTER, IN
(219) 836-2995

Practice Location

540 Litchfield St, Torrington, CT
(972) 449-0540

Quick Facts

NPI
1265436042
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
34
Publications
20

Are you this provider?

Claim Your Profile